Evaluation of a Behavioral Intervention to Optimize Supplement Adherence in Ethiopia

Not Applicable

• Conditions: Adherence, Patient

• Registration Number: NCT06479109
• Lead Sponsor: Johns Hopkins Bloomberg School of Public Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-6-24
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: All
• Target Recruitment: 5096

Inclusion Criteria

Inclusion Criteria:<br><br> - Pregnant women:<br><br> - Between 15 and 49 years of age.<br><br> - Have had at least one ANC visit and received IFAS or MMS in the prior four<br> months.<br><br> - For unmarried 15-18 years of age: agree for her parent/guardian to be<br> contacted.<br><br> - Women in Intervention sites: Have received and used the intervention materials<br> for at least one month.<br><br> - Health providers in intervention sites:<br><br> - Provide antenatal care and/or coordinate IFAS/MMS service provision at the<br> clinic or post level.<br><br> - Health volunteers working in health extension services are 19 years or older<br> and actively engaged in the implementation of the intervention<br><br>Exclusion Criteria:<br><br> - Pregnant women<br><br> - Receiving IFAS supplementation for the treatment of anemia.<br><br> - For unmarried 15-18 years of age: her parent/guardian lives outside the study<br> woreda/district.<br><br> - For Intervention sites: Has not attended ANC visits in the prior 4-6 months and<br> did not receive the intervention materials.<br><br> - Health providers in intervention sites:<br><br> - Have worked for less than six months in the health center or the health post at<br> the intervention sites.<br><br> - Health volunteers working in health extension services are younger than 19<br> years old and not involved in house visits.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of pregnant women who report consuming five or more [ 80 percent] IFA/MMS tablets in the past week;Percentage of pregnant women who report consuming 24 or more [80 percent] IFA/MMS tablets in the last 30 days [past month];Percentage of pregnant women who report consuming 90 or more IFA/MMS tablets during the entire pregnancy;Total number of pills provided based on the count of IFAS blister/strips or MMS pills in bottles;Total number of pills consumed based on the count of IFAS blister/strips or MMS pills in bottles